A new tool is needed to provide prevention in being affected by HIV. It must be used in combination with other methods in order to reduce HIV transmission.
According to scientists, the low-dose aspirin, the affordable and globally available drug might be this tool that aims to help prevent HIV transmission.
African young women are the most common to be infected by HIV and infection rates rise day by day.
How would aspirin help?
The researchers from the University of Manitoba in Canada conducted a series of tests on Kenyan women. They tested the effect of aspirin in combination with other anti-inflammatory drugs on HIV target cells.
Aspirin is usually used for long-term prevention of cardiovascular disease, and it was given to the women in the same low dose every day.
The Journal of the International AIDS Society published the pilot study which was built on information already known about what role inflammation has in HIV transmission.
What were the results?
According to the researchers, Aspirin can reduce by 35 percent the of HIV target cells in the female genital tract.
“Further research is needed to confirm our results with aspirin and test whether this level of target cell reduction will actually prevent HIV infections,” said Keith R Fowke from the University of Manitoba.
“If so, this could be a strategy for HIV prevention that is not only inexpensive but easily accessed globally. People living in poverty are disproportionately at risk of acquiring HIV. We need prevention approaches that are affordable and immediately available,” said Fowke.
“The goal is to provide a new tool in the HIV prevention arsenal that would be used together with other approaches to reduce HIV transmission in high-risk populations,” Fowke said.
Aspirin can be used more regularly than the other HIV prevention drugs.